Paracelsian Inc (PRLN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Paracelsian Inc (PRLN)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: richard davis who wrote (392)	9/6/1996 3:45:00 PM
From: Richard Mazzarella	of 4342

Richard, you're right, it ain't so. I just listened to the tape again and PN355 is effective against immune system distruction and HIV replication and will be on the market. However PRLN will extend the trials to include the combinational drugs of which PN355 will be the foundation. PRLN will go for national and international sales. Sorry to concern everyone. My memory needs a tune-up.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next